[HTML][HTML] Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV …
T Zhao, X Xu, Y Wu, W Zhang, Q Zeng, Y Lu… - BMC Infectious …, 2022 - Springer
Background The most appropriate alternative to induction therapy for HIV-associated
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
[HTML][HTML] Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV …
T Zhao, X Xu, Y Wu, W Zhang, Q Zeng, Y Lu… - BMC Infectious …, 2022 - ncbi.nlm.nih.gov
Background The most appropriate alternative to induction therapy for HIV-associated
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV …
T Zhao, X Xu, Y Wu, W Zhang, Q Zeng, Y Lu, T Yang… - 2022 - cabidigitallibrary.org
Background: The most appropriate alternative to induction therapy for HIV-associated
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV …
T Zhao, X Xu, Y Wu, W Zhang, Q Zeng, Y Lu… - BMC Infectious …, 2022 - europepmc.org
Background The most appropriate alternative to induction therapy for HIV-associated
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV …
T Zhao, X Xu, Y Wu, W Zhang, Q Zeng… - BMC Infectious …, 2022 - search.proquest.com
Background The most appropriate alternative to induction therapy for HIV-associated
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV …
T Zhao, X Xu, Y Wu, W Zhang, Q Zeng… - BMC Infectious …, 2022 - search.ebscohost.com
Abstract < bold> Background: </bold> The most appropriate alternative to induction
therapy for HIV-associated cryptococcal meningitis (CM) remains unclear when standard …
therapy for HIV-associated cryptococcal meningitis (CM) remains unclear when standard …
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV …
T Zhao, X Xu, Y Wu, W Zhang, Q Zeng… - BMC infectious …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The most appropriate alternative to induction therapy for HIV-associated
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
cryptococcal meningitis (CM) remains unclear when standard treatment is unavailable …
[HTML][HTML] Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV …
T Zhao, X Xu, Y Wu, W Zhang… - BMC Infectious …, 2022 - bmcinfectdis.biomedcentral.com
The most appropriate alternative to induction therapy for HIV-associated cryptococcal
meningitis (CM) remains unclear when standard treatment is unavailable, inaccessible …
meningitis (CM) remains unclear when standard treatment is unavailable, inaccessible …